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Background
Hepatitis B viral represents a pathology with a severe
impact on public health. Worldwide, approximately 350
million individuals are chronically infected with hepatitis
B virus (HBV). HBV is the leading cause of cirrhosis
globally. Once chronic infection is established, approxi-
mately 30% of the patients will develop cirrhosis, and
approximately one-quarter of patients with cirrhosis will
develop decompensated liver disease within 5 years.
Cirrhosis also substantially increases the risk for hepato-
cellular carcinoma (HCC).
Methods
In the study were included 73 patients with acute hepatitis
B viral with a mean age of 33.20±1.46 years that were hos-
pitalized in the Toma Ciorbă Infectious Diseases Clinical
Hospital. The analysis parameters: age, sex, onset, clinical
manifestation, liver size, disease level, total bilirubin,
ALAT, thymol test, prothrombin.
Results
Acute viral hepatitis B has been observed in the both
sexes: women – 27 (37%), men – 46 (63%). The disease
with the acute onset has been manifested in 73 patients
(100%), more frequently in icteric form in 65 patients
(89%), than in anicteric form in 8 patients (11%). In
1.4% of acute HBV patients it occurred in a milder
form: in 65.8% – mild and in 32.8% – severe form. The
preicteric period lasted 7.51±0.57 days. Acute B viral
hepatitis includes asthenic, dyspeptic and mesenchymal
inflammatory syndrome. Biochemical investigations:
increased level of bilirubin 184.54±14.18 mkmol/L, ALT
constitutes 11.02±0.38 mmol/h/L, thymol test 11.29
±0.74 U and prothrombin index – 70.99±1.51%. Hepato-
megaly was 3.5±0.16 cm in all patients (100%), and
splenomegaly – 2.0±0.2 cm in 39 patients (53.4%).
Conclusion
Acute hepatitis B virus affects both sexes, being more
frequent in men, and is manifested through acute onset in
the icteric form, the moderate form being characterized
clinically by the dyspeptic, asthenic, and biochemical
syndrome through the ALT activity increase, bilirubin and
thymol test.
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